USE OF PHENTERMINE/TOPIRAMATE EXTENDED-RELEASE (PHEN/TPM ER) IN OBESE/OVERWEIGHT SUBJECTS WITH DYSGLYCEMIA

  • Handelsman, Yehuda MD
  • Odeh, Sarah BS
  • Troupin, Barbara MD

  • aMetabolic Institute of America, Tarzana, CA; bVIVUS, Inc., Mountain View, CA

Endocrine Practice 20(1):p 40A-41A, January 2014.
Copyright © 2014 Allen Press
View full text|Download PDF